Alpha 2.0
Login Register
» Authors » K R Rabin

K R Rabin

Explore the profile of K R Rabin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 189
Followers 0
Related Specialties
Oncology
Hematology
Pediatrics
Top 10 Co-Authors
C M Bollard
M Devidas
A J Carroll
H Liu
A Pession
S P Hunger
G Weber
M J Burke
E J Shpall
G Basso
Published In
Leukemia
Pediatr Hematol Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Enhanced Risk Stratification for Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia: A Children's Oncology Group Report
DelRocco N, Loh M, Borowitz M, Gupta S, Rabin K, Zweidler-McKay P, et al.
Leukemia . 2024 Feb; 38(4):720-728. PMID: 38360863
Current strategies to treat pediatric acute lymphoblastic leukemia rely on risk stratification algorithms using categorical data. We investigated whether using continuous variables assigned different weights would improve risk stratification. We...
2.
Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study
Gossai N, Bhojwani D, Schafer E, Chang B, Pommert L, Verma A, et al.
Leukemia . 2023 Feb; 37(5):1138-1140. PMID: 36813993
No abstract available.
3.
The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia
Rouce R, Shaim H, Sekine T, Weber G, Ballard B, Ku S, et al.
Leukemia . 2015 Dec; 30(4):800-11. PMID: 26621337
Natural killer (NK) cells are key components of the innate immune system, providing potent antitumor immunity. Here, we show that the tumor growth factor-β (TGF-β)/SMAD signaling pathway is an important...
4.
Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant
Weber G, Gerdemann U, Caruana I, Savoldo B, Hensel N, Rabin K, et al.
Leukemia . 2013 Mar; 27(7):1538-47. PMID: 23528871
Adoptive immunotherapy with ex vivo expanded T cells is a promising approach to prevent or treat leukemia. Myeloid leukemias express tumor-associated antigens (TAA) that induce antigen-specific cytotoxic T lymphocyte (CTL)...
5.
Pediatric Hodgkin lymphoma: are we over-scanning our patients?
Rathore N, Eissa H, Margolin J, Liu H, Wu M, Horton T, et al.
Pediatr Hematol Oncol . 2012 May; 29(5):415-23. PMID: 22632168
Despite the favorable outcome of most pediatric patients with Hodgkin lymphoma (HL), there is rising concern about risks of carcinogenesis from both diagnostic and therapeutic radiation exposure for patients treated...
6.
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles
Loudin M, Wang J, Leung H, Gurusiddappa S, Meyer J, Condos G, et al.
Leukemia . 2011 Jun; 25(10):1555-63. PMID: 21647151
Patients with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) have distinct clinical and biological features. Whereas most DS-ALL cases lack the sentinel cytogenetic lesions that guide risk assignment in...
7.
Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia
Blink M, Buitenkamp T, van den Heuvel-Eibrink M, Danen-van Oorschot A, de Haas V, Reinhardt D, et al.
Leukemia . 2011 May; 25(8):1365-8. PMID: 21537335
No abstract available.